Your browser doesn't support javascript.
loading
Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy.
Oehus, Ann-Kathrin; Kroeze, Stephanie G C; Schmidt-Hegemann, Nina-Sophie; Vogel, Marco M E; Kirste, Simon; Becker, Jessica; Burger, Irene A; Derlin, Thorsten; Bartenstein, Peter; Eiber, Matthias; Mix, Michael; la Fougère, Christian; Belka, Claus; Combs, Stephanie E; Grosu, Anca-Ligia; Müller, Arndt-Christian; Guckenberger, Matthias; Christiansen, Hans; Henkenberens, Christoph.
Afiliação
  • Oehus AK; Department of Radiotherapy and Special Oncology, Hannover Medical School, Carl-Neuberg-Str. 1, 30629, Hannover, Germany.
  • Kroeze SGC; Department of Radiation Oncology, University Hospital Zürich, University of Zurich, Zurich, Switzerland.
  • Schmidt-Hegemann NS; Department of Radiation Oncology, University Hospital LMU Munich, Munich, Germany.
  • Vogel MME; Department of Radiation Oncology, Technical University Munich, Munich, Germany.
  • Kirste S; Department of Radiation Oncology, University of Freiburg, Freiburg, Germany.
  • Becker J; German Cancer Consortium (DKTK) Partner Site Freiburg, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Burger IA; Department of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany.
  • Derlin T; Department of Nuclear Medicine, University Hospital Zürich, Zürich, Switzerland.
  • Bartenstein P; Department of Nuclear Medicine, Hannover Medical School, Hanover, Germany.
  • Eiber M; Department of Nuclear Medicine, University Hospital LMU Munich, München, Germany.
  • Mix M; Department of Nuclear Medicine, Technical University Munich, München, Germany.
  • la Fougère C; Department of Nuclear Medicine, University of Freiburg, Freiburg, Germany.
  • Belka C; Department of Nuclear Medicine, University Hospital Tübingen, Tübingen, Germany.
  • Combs SE; Cluster of Excellence iFIT (EXC 2180) "Image Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Germany.
  • Grosu AL; German Cancer Consortium (DKTK) Partner Site Tübingen, Tübingen, Germany.
  • Müller AC; Department of Radiation Oncology, University Hospital LMU Munich, Munich, Germany.
  • Guckenberger M; German Cancer Consortium (DKTK) Partner Site Munich, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Christiansen H; Department of Radiation Oncology, Technical University Munich, Munich, Germany.
  • Henkenberens C; Institute of Innovative Radiotherapy (iRT), Oberschleissheim, Germany.
BMC Cancer ; 20(1): 362, 2020 Apr 29.
Article em En | MEDLINE | ID: mdl-32349700
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Glutamato Carboxipeptidase II / Recidiva Local de Neoplasia / Antígenos de Superfície Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Glutamato Carboxipeptidase II / Recidiva Local de Neoplasia / Antígenos de Superfície Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido